Ipca Laboratories Ltd.
IPCALAB
13.25
0.00 (-1.12%)Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India
Shareholding Pattern
| On | Ind. Pro. | Fore. Pro. | FII/FPI | Mutual Funds | Banks | Insurance | Others | Non/Institution |
|---|---|---|---|---|---|---|---|---|
| 2024-12 | 44.72 | 0 | 11.06 | 29.63 | 0 | 5.19 | 0.86 | 8.53 |
| 2024-09 | 46.3 | 0 | 10.83 | 28.55 | 0 | 4.87 | 0.80 | 8.65 |
| 2024-06 | 46.3 | 0 | 10.85 | 28.52 | 0.01 | 4.63 | 0.62 | 9.07 |
| 2024-03 | 46.3 | 0 | 10.51 | 28.83 | 0.01 | 4.67 | 0.86 | 8.82 |
| 2023-12 | 46.29 | 0 | 10.27 | 29.25 | 0 | 4.54 | 0.73 | 8.92 |
| 2023-09 | 46.29 | 0 | 9.86 | 30.23 | 0 | 4.12 | 0.70 | 8.81 |
| 2023-06 | 46.29 | 0 | 10.05 | 30.27 | 0.01 | 4.26 | 0.64 | 8.47 |
| 2023-03 | 46.29 | 0 | 10.58 | 29.94 | 0 | 3.61 | 0.51 | 9.07 |
| 2022-12 | 46.29 | 0 | 10.46 | 29.79 | 0 | 3.76 | 0.48 | 9.22 |
Results
| On | Income from Inv. | Int. on Bank Bal. | Int. on Advances | Other Int. | Interest Earned | Interest Exp. | Net Interest Income | Expenditure | Operating Income | Other Income | Prov. & Contingencies | PBT | Tax | PAT | Net Profit | Consolidated Net Profit | Adjusted EPS(Rs.) | Gross NPA | Gross NPA(%) | Net NPA | Net NPA(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09 | 0 | 0 | 0 | 0 | 2354.9 | 22.56 | 2332.34 | 1913.42 | 467.74 | 26.26 | 0 | 344.83 | 99.39 | 245.44 | 245.44 | 229.48 | 9.05 | 0 | 0% | 0 | 0% |
| 2024-06 | 0 | 0 | 0 | 0 | 2092.63 | 24.05 | 2068.58 | 1699.91 | 413.33 | 20.61 | 0 | 290.39 | 91.41 | 198.98 | 198.98 | 192.24 | 7.58 | 0 | 0% | 0 | 0% |
| 2024-03 | 0 | 0 | 0 | 0 | 2033.01 | 29.37 | 2003.64 | 1711.11 | 340.82 | 18.92 | 0 | 76.6 | 73.69 | 2.91 | 2.91 | 59.59 | 2.35 | 0 | 0% | 0 | 0% |
| 2023-12 | 0 | 0 | 0 | 0 | 2052.86 | 33.4 | 2019.46 | 1721.53 | 353.78 | 22.45 | 0 | 288.89 | 66.24 | 222.65 | 222.65 | 179.88 | 7.09 | 0 | 0% | 0 | 0% |
| 2023-09 | 0 | 0 | 0 | 0 | 2033.95 | 44.12 | 1989.83 | 1673.39 | 399.11 | 38.55 | 0 | 225.36 | 87.92 | 137.44 | 137.44 | 145.06 | 5.72 | 0 | 0% | 0 | 0% |
| 2023-06 | 0 | 0 | 0 | 0 | 1585.21 | 31.38 | 1553.83 | 1277.39 | 352.67 | 44.85 | 0 | 251.82 | 85.61 | 166.21 | 166.21 | 162.82 | 6.42 | 0 | 0% | 0 | 0% |
| 2023-03 | 0 | 0 | 0 | 0 | 1511.63 | 18.45 | 1493.18 | 1330.59 | 217.43 | 36.39 | 0 | 129.44 | 48.37 | 81.07 | 81.07 | 76.52 | 3.02 | 0 | 0% | 0 | 0% |
| 2022-12 | 0 | 0 | 0 | 0 | 1546 | 10.84 | 1535.16 | 1330.14 | 246.75 | 30.89 | 0 | 169.34 | 53.73 | 115.61 | 115.61 | 107.84 | 4.25 | 0 | 0% | 0 | 0% |
| 2022-09 | 0 | 0 | 0 | 0 | 1600.95 | 9.31 | 1591.64 | 1340.31 | 296.87 | 36.23 | 0 | 223.82 | 77 | 146.82 | 146.82 | 143.9 | 5.67 | 0 | 0% | 0 | 0% |
| 2022-06 | 0 | 0 | 0 | 0 | 1585.74 | 6.94 | 1578.8 | 1316.51 | 291.34 | 22.11 | 0 | 222.69 | 74.26 | 148.43 | 148.43 | 143.06 | 5.64 | 0 | 0% | 0 | 0% |